Skip to content
Anticancer Bioscience
  • Home
  • About Us
    • Our Heritage
    • Operations
    • Team
    • Investors
  • Science
    • Discovery Platforms
    • Pipeline
    • Publications
  • Partners
    • Academic Partners
    • Commercial Partners
  • News & Events
    • Press Releases
    • Events
    • In the News
  • Careers
  • Contact Us
Anticancer Bioscience

In the News

February 11, 2023

“We need to foster risky projects that can have large rewards”

Read More
August 1, 2022

From Chengdu To The World: Anticancer Takes Novel Approach To Cancer Drug Development

Read More
February 4, 2022

Embrace new things and new ideas as curiosity drives creativity and innovation

Read More
January 7, 2022

Pharma’s Almanac Roundtable: For what therapeutic area do you think we will see the greatest progress in the coming years?

Read More
January 7, 2022

Pharma’s Almanac Roundtable: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?

Read More
October 25, 2021

Anticancer Bioscience: A Precision Therapeutics Company Dedicated to Discovering and Developing Breakthrough Cancer Therapies for Unmet Oncology Needs Around the World

Read More
September 4, 2021

Treating Cancer with Novel Synthetic Lethal Therapies

Read More
July 23, 2021

Mini-library Approach Delivers an Arsenal in Drug Development Pipeline

Read More
July 14, 2021

Anticancer Bioscience appoints Dr. Hong Liu, as US-based VP of clinical development

Read More
July 14, 2021

ACB hires Liu from Eureka Therapeutics to lead push into clinic

Read More
June 14, 2021

Anticancer Bioscience: applying synthetic lethality to MYC-driven cancers

Read More
June 7, 2021

Dun Yang – President & CEO, Anticancer Bioscience

Read More
March 25, 2021

Synthetic lethal drugs vs. cancer

Read More
February 9, 2021

Anticancer Bioscience Raises $10M to Advance Synthetic Lethality Programs

Read More
February 9, 2021

China’s Anticancer Bioscience raises $10 million, aims high in China

Read More
February 8, 2021

Anticancer Bioscience announces $10 million financing

Read More
February 8, 2021

A synthetic lethality player emerges in China, armed with lessons on undruggable oncogene from Nobel laureate’s lab

Read More
  • Chengdu, China
  • St Andrews, UK
  • San Francisco, USA
  • Sydney, Australia
  • Hyderabad, India
  • Linkedin
  • Twitter
  • Anticancer Bioscience © 2021
  • info@anticancerbio.com

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.

  • Home
  • About Us
    • Our Heritage
    • Operations
    • Team
    • Investors
  • Science
    • Discovery Platforms
    • Pipeline
    • Publications
  • Partners
    • Academic Partners
    • Commercial Partners
  • News & Events
    • Press Releases
    • Events
    • In the News
  • Careers
  • Contact Us